India's Caplin Point rises on no observations in US FDA inspection

Caplin Point Laboratories

07/01/2025 04:19

** Shares of drugmaker Caplin Point Laboratories  CAPL.NS  rise
about 2%
** Latin America and Africa-focussed co says the U.S. Food and
Drug Administration conducted an unannounced inspection at its
unit's Gummidipoondi facility in August 2024
    ** The inspection was concludes with zero 483 observations,
co says
    ** Stock surged over 84% in 2024

(Reporting by Hritam Mukherjee in Bengaluru)
((Hritam.Mukherjee@thomsonreuters.com;))